Welcome to the e-CCO Library!

P590: ADVANCED-UC TRIAL: AppenDectomy Vs ANti TNF-a in inducing Clinical and EnDoscopic remission in left-sided Ulcerative Colitis – A Randomized Clinical Trial
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Luglio, G.(1)*;Rispo, A.(2);Tropeano, F.P.(3);Cricrì, M.(2);Castiglione, F.(2);De Palma, G.D.(2);
Created: Friday, 14 July 2023, 11:05 AM
P590: Laparoscopy in Crohn’s disease: Learning curve and current practice
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Mege1,2*, F. Michelassi1

Created: Thursday, 21 February 2019, 9:14 AM
P590: Reasons for discontinuation and switch of biologic therapy in IBD: findings from a large international observational study (03)
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sebastian S.*1, Lewis J.D.2, Siegmund B.3, Wolf D.4, Siegel C.A.5, Lichtenstein G.2, Louis E.6, Hebuterne X.7, Ginsburg P.M.8, Ostrov A.9, Ricci M.Q.10, Bernsen M.11, Shafran I.12, Nancey S.13, Moran G.14, Teich N.15, Lal S.16, Kiszka-Kanowitz M.17, Murugesan S.18, Moum B.19, Dolin P.20

Created: Wednesday, 20 February 2019, 10:36 AM
P590: Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel
Year: 2022
Source: ECCO'22
Authors: Hansen, R.(1);Meade, S.(2);Torrente, F.(3);Kammermeier, J.(4);Croft, N.M.(5);de Ridder, L.(6);Wilson, D.C.(7);Klomberg, R.(6);Turner, D.(8);Martín-de-Carpi, J.(9);Bronsky, J.(10);Benchimol, E.(11);Amil-Dias, J.(12);Mack, D.R.(13);Walker, G.(14);Powar, M.(15);Burgess, N.(16);van Ommen, C.H.(17);Irving, P.M.(18);Samaan, M.(18);
Created: Friday, 11 February 2022, 3:56 PM
P590: Which biomarkers have an effect on therapeutic vedolizumab drug levels? A retrospective analysis from a London Tertiary Centre.
Year: 2021
Source: ECCO'21 Virtual
Authors: Bancil, A.(1);Stevens, M.(2);Kok, K.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P591 Therapeutic management in inflammatory bowel disease: Differences in two IBD inception cohorts: 1991–93 and 2010–11 enrolled in the north-west of Spain
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.L. De Castro Parga, V. Hernández, L. Sanroman, J.R. Pineda, M. Figueira, J. Martinez-Cadilla, S. Pereira, J.I. Rodriguez-Prada

Created: Thursday, 30 January 2020, 10:12 AM
P591: Anti-TNF therapy for Ulcerative Colitis in Brazil: a comparative real-world national multicentric study from the Brazilian Study Group of IBD (GEDIIB).
Year: 2021
Source: ECCO'21 Virtual
Authors: Sassaki, L.Y.(1);Magro, D.O.(2);Saad-Hossne, R.(3);Baima, J.P.(1);Flores, C.(4);Correia, L.P.D.M.P.(5);Ferrari, M.D.L.D.A.(6);Zacharias, P.(7);Feitosa, M.R.(8);Santos, C.H.M.(9);Lins Neto, M.A.D.F.(10);Quaresma, A.B.(11);Lima Junior, S.F.(12);Vasconcelos, G.B.S.(13);Cassol, O.(14);Pinto, A.D.S.(15);Kurachi, G.(16);Goncalves Filho, F.D.A.(17);Gasparini, R.G.(18);Furlan, T.K.(19);Catapani, W.(20);Coy, C.S.R.(2);Menegassi, V.D.S.(21);Colombo, M.M.(22);Froes, R.D.S.B.(23);Teixeira, F.V.(3);Moraes , A.C.(24);Santana , G.O.(25);Parente, J.M.L.(26);Vilela , E.G.(27);Kotze , P.G.(7);
Created: Wednesday, 2 June 2021, 4:12 PM
P591: Biological therapies and small molecules show to be efficacious in patients with moderate-to-severe ulcerative proctitis.
Year: 2022
Source: ECCO'22
Authors: Lemmens, P.(1);Guedelha Sabino, J.(1,2);Dubois, E.(1);Verstockt, B.(1,2);Vermeire, S.(1,2);Ferrante, M.(1,2);
Created: Friday, 11 February 2022, 3:56 PM
P591: Gastroenterologist performed point-of-care gastrointestinal ultrasound improves patient understanding of disease activity, symptomatology, management decisions and clinical outcomes
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Friedman1*, A. Asthana1,2, S. Knowles3, A. Robbins4, P. Gibson1

Created: Thursday, 21 February 2019, 9:14 AM
P591: Low donor microbial engraftment after combined endoscopic and oral faecal microbiota transplant (FMT) in patients with antibiotic dependent pouchitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H. Herfarth*1, E. L. Barnes1, M. D. Long1, K. L. Isaacs1, T. Leith2, M. Silverstein3, Y. Gerardin3, Z. Kassam3

Created: Friday, 22 February 2019, 9:41 AM
P591: Negative impact of high body mass index on the efficacy of anti-TNFα agents in patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hamoir, F.(1)*;De Leuze, F.(1);Denis, M.(1);De Vroey, B.(1);De Suray, N.(1);Burnet, G.(1);Piessevaux, H.(1);Dewit, O.(1);
Created: Friday, 14 July 2023, 11:05 AM
P591: Therapeutic drug monitoring in Paediatric inflammatory bowel disease on maintenance infliximab and adalimumab treatment improves clinical remission with a proactive approach
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Chadokufa S.*1, Sider S.1, Huggett B.1, Sawney T.1, Shah N.1, Baycheva M.1, Zambrano Perez A.1, Acton N.1, Kiparissi F.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P592 Frequency and causes of prolongation of the induction course of tofacitinib in patients with ulcerative colitis in conditions of real clinical practice
Year: 2020
Source:

ECCO'20 Vienna

Authors:

O. Knyazev, A. Kagramanova, A. Lishchinskaya, A. Parfenov

Created: Thursday, 30 January 2020, 10:12 AM
P592: Clinical evaluation of leukocytapheresis compared to vedolizumab in patients with Ulcerative Colitis with contraindications to anti-TNF-alpha: a single-centre experience
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ferronato, A.(1)*;Rigno, M.(2);Rodriguez-Castro, K.I.(1);Brozzi, L.(1);Errigo, G.(2);Castelli, M.(2);Baldassarre, G.(1);
Created: Friday, 14 July 2023, 11:05 AM
P592: Costs savings associated with ferric maltol and the reduced use of intravenous iron based on real world data
Year: 2021
Source: ECCO'21 Virtual
Authors: Howaldt, S.(1,2,3);Becker, C.K.(4);Becker, J.A.(4);Poinas , A.C.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P592: Effectiveness and safety of thioguanine in thiopurine-naïve Inflammatory Bowel Disease patients
Year: 2022
Source: ECCO'22
Authors: Crouwel, F.(1);Bayoumy, A.B.(1);Mulder, C.J.J.(1);Peters, J.H.C.(2);Boekema, P.J.(3);Derijks, L.J.J.(4);De Boer, S.Y.(5);van de Meeberg, P.C.(5);Ahmad, I.(6);Buiter, H.J.C.(7);de Boer, N.K.(1);
Created: Friday, 11 February 2022, 3:56 PM
P592: Efficacy of vedolizumab for induction and maintenance of clinical remission in ulcerative colitis: The UCLH experience
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Vinayaga-Pavan*, T. Kumagai, I. Parisi, J. Barragry, R. Sundramoorthi, L. Whitley, H. Parker, R. Kettle, N. McCabrey, E. Steward, S. McCartney, S. Bloom, R. Vega, S. Mehta, F. Rahman

Created: Thursday, 21 February 2019, 9:14 AM
P592: Final results on immunogenicity profile and predictors of ADA development of biosimilar infliximab during the first 12 months of the therapy: results from a prospective nationwide cohort
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lovasz B.D.*1, Kurti Z.1, Rutka M.2, Vegh Z.1, Gecse K.B.1, Farkas K.2, Banai J.3, Bene L.4, Golovics P.A.1, Gonczi L.1, Gasztonyi B.5, Kristof T.6, Lakatos L.7, Miheller P.8, Palatka K.9, Patai A.10, Papp M.9, Salamon A.11, Szamosi T.3, Szepes Z.2, Toth G.T.12, Vincze A.13, Szalay B.14, Molnar T.2, Lakatos P.L.1

Created: Wednesday, 20 February 2019, 10:36 AM
P592: Towards a Food Pharmacy: increased dietary quality reduces CRP and improves quality of life in IBD patients in remission
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Molendijk*1, J. E. Martens1, E. van Lingen1, S. van der Marel1, M. E. van Veen-Lievaart2, A. E. van der Meulen1, M. C. Barnhoorn1, A. M. Ernst-Stegeman3, J. Maljaars1

Created: Friday, 22 February 2019, 9:41 AM
P593 Predictors of steroid-resistance in severe colitis of inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. JEMMALI1, A. Labidi2, M.A. Jouini2, M. Hafi2, M. Serghini2, M. Fekih2, J. Boubaker2

Created: Thursday, 30 January 2020, 10:12 AM